Interpace Biosciences®, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Liquidity (Details Narrative)

Liquidity (Details Narrative) - USD ($)												1 Months Ended		12 Months Ended
Liquidity (Details Narrative) - USD ($)	Oct. 31, 2017	Oct. 12, 2017	Sep. 30, 2017	Jul. 31, 2017	Jun. 21, 2017	Jun. 16, 2017	Apr. 18, 2017	Mar. 22, 2017	Feb. 08, 2017	Jan. 25, 2017	Jan. 06, 2017	Apr. 18, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Jul. 07, 2017	Jul. 05, 2017	Sep. 28, 2016	Dec. 31, 2015	Oct. 31, 2014
Cash and cash equivalents													$ 602,000	$ 15,199,000	$ 602,000				$ 8,310,000
Accounts receivable, net													2,209,000	3,437,000	2,209,000
Total current assets													4,240,000	19,808,000	4,240,000
Total current liabilities													16,241,000	8,091,000	16,241,000
Net loss														12,216,000	8,332,000
Net cash used in operating activities														15,263,000	7,607,000
Gross proceeds from sale of equity														34,000,000
Proceeds from issuance of sale of equity														29,900,000
Number of common stock shares issued					9,900,000
Common stock issued price per share				$ 1.09
Warrant exercise price		$ 1.25															$ 1.25
Gross proceeds from equity offerings				$ 960,000										29,900,000
Underwriters over-allotment option to purchase common stock				875,000		1,875,000
Proceeds from exercise of warrants	$ 1,200,000		$ 900,000											6,861,000
Warrants exercised	925,000	4,000,000	747,800
Other (expense) income														(2,128,000)	14,000
SCM Specialty Finance Opportunities Fund, L.P. [Member]
Line of credit																		$ 1,200,000
Senior Secured Convertible Note [Member]
Debt conversion, converted instrument, shares issued												3,795,429
RedPath Note [Member]
Debt instrument, face amount													9,340,000		$ 9,340,000					$ 10,700,000
Repayments of debt													$ 1,330,000
RedPath Note [Member] \| Senior Secured Convertible Note [Member]
Debt instrument, face amount								$ 5,320,000
RedPath Note [Member] \| Senior Secured Non-Convertible Note [Member]
Debt instrument, face amount								3,550,000						3,550,000
Debt conversion, converted instrument, shares issued							3,795,429					3,795,429
RedPath Note [Member] \| Investor [Member]
Business combination cash acquired								$ 8,870,000
RedPath Note [Member] \| Investor [Member] \| Senior Secured Non-Convertible Note [Member]
Debt instrument, face amount							$ 3,550,000					$ 3,550,000
Base Warrants [Member]
Number of common stock shares issued					12,500,000
Gross proceeds from equity offerings					$ 13,700,000
Underwriters over-allotment option to purchase common stock						1,875,000
Proceeds from exercise of warrants														$ 6,200,000
Pre-Funded Warrants [Member]
Number of common stock shares issued					2,600,000
Warrant to purchase shares of common stock					2,600,000
Warrant exercise price						$ 1.09								$ 0.01		$ 0.01
Gross proceeds from equity offerings					$ 12,300,000
First Registered Direct Offering [Member]
Proceeds from issuance of sale of equity											$ 4,300,000
Number of common stock shares issued											630,000
Common stock issued price per share											$ 6.81
Second Registered Direct Offering [Member]
Number of common stock shares issued										855,000
Warrant to purchase shares of common stock										855,000
Second Registered Direct Offering and Private Placement [Member]
Proceeds from issuance of sale of equity										$ 4,000,000
Confidentially Marketed Public Offering [Member]
Proceeds from issuance of sale of equity									$ 3,900,000
Number of common stock shares issued									1,200,000
Common stock issued price per share									$ 3.00
Public Offering [Member] \| Base Warrants [Member]
Number of common stock shares issued					9,900,000
Common stock issued price per share					$ 1.10
Prefunded warrants of shares					2,600,000
Warrant exercise price					$ 1.09
Private Placement [Member]
Warrant exercise price		$ 1.80
Proceeds from exercise of warrants		$ 5,000,000
Warrants exercised		3,200,000